Comparing measures of cystatin C in human sera by three methods

American Journal of Nephrology

Volumn 29, Issue 5, 2009, Pages 381-391

  Hossain, Mohammad Akhtar ^a,b   Emara, Mahmoud ^a   El Moselhi, Hamdi ^a   Shoker, Ahmed ^a,b  

^a UNIVERSITY OF SASKATCHEWAN   (Canada)

^b UNIVERSITY OF SASKATCHEWAN   (Canada)

Author keywords

Cystatin C; ELISA; Glomerular filtration rate; Nephelometry; Turbidimetry

Indexed keywords

CYSTATIN C;

ARTICLE; COMPARATIVE STUDY; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DRUG BLOOD LEVEL; ENZYME LINKED IMMUNOSORBENT ASSAY; HEART DISEASE; HUMAN; IMMUNOASSAY; KIDNEY DISEASE; PARTICLE ENHANCED NEPHELOMETRIC IMMUNOASSAY; PARTICLE ENHANCED TURBIDIMETRIC IMMUNOASSAY; PRIORITY JOURNAL; SEROLOGY;

CYSTATIN C; ENZYME-LINKED IMMUNOSORBENT ASSAY; HUMANS; NEPHELOMETRY AND TURBIDIMETRY; ROC CURVE; SENSITIVITY AND SPECIFICITY;

EID: 54949097737     PISSN: 02508095     EISSN: None     Source Type: Journal    
DOI: 10.1159/000168486     Document Type: Article

References (35)

1. Mussap M, Plebani M: Biochemistry and clinical role of human cystatin C. Crit Rev Clin Lab Sci 2004;41:467-550.
2. Newman DJ: Cystatin C. Ann Clin Biochem 2002;39:89-104.
3. Grubb AO: Cystatin C - properties and use as diagnostic marker. Adv Clin Chem 2000; 35:63-99.
4. Grubb A: Diagnostic value of analysis of cystatin C and protein HC in biological fluids. Clin Nephrol 1992;38(suppl 1):S20-S27.
5. Jonsson AS, Flodin M, Hansson LO, Larsson A: Estimated glomerular filtration rate (eGFRCystC) from serum cystatin C shows strong agreement with iohexol clearance in patients with low GFR. Scand J Clin Lab Invest 2007;67:801-809.
6. Larsson A, Helmersson J, Hansson LO, Basu S: Serum cystatin C is associated with other cardiovascular risk markers and cardiovascular disease in elderly men. Int J Cardiol 2008; 125:263-264.
7. Arpegard J, Ostergren J, de Faire U, et al: Cystatin C - a marker of peripheral atherosclerotic disease? Atherosclerosis 2008; 199: 397-401.
8. Shlipak MG, Ix JH, Bibbins-Domingo K, et al: Biomarkers to predict recurrent cardiovascular disease: the Heart and Soul Study. Am J Med 2008; 121:50-57.
9. Ix JH, Katz R, Kestenbaum B, et al: Association of mild to moderate kidney dysfunction and coronary calcification. J Am Soc Nephrol 2008; 19:579-585.
10. Rule AD, Bergstralh EJ, Slezak JM, et al: Glomerular filtration rate estimated by cystatin C among different clinical presentations. Kidney Int 2006;69:399-405.
11. Hoek FJ, Kemperman FA, Krediet RT: A comparison between cystatin C, plasma cre-atinine and the Cockcroft and Gault formula for the estimation of glomerular filtration rate. Nephrol Dial Transplant 2003; 18:2024-2031.
12. Le Bricon T, Thervet E, Froissart M, et al: Plasma cystatin C is superior to 24 h creati-nine clearance and plasma creatinine for estimation of glomerular filtration rate 3 months after kidney transplantation. Clin Chem 2000;46:1206-1207.
13. Filler G, Lepage N: Should the Schwartz formula for estimation of GFR be replaced by the cystatin C formula? Pediatr Nephrol 2003; 18:981-985.
14. Larsson A, Malm J, Grubb A, Hansson LO: Calculation of glomerular filtration rate expressed in ml/min from plasma cystatin C values in mg/1. Scand J Clin Lab Invest 2004; 64:25-30.
15. Grubb A, Bjork J, Lindstrom V, et al: A cystatin C-based formula without anthropo-metric variables estimates glomerular filtration rate better than creatinine clearance using the Cockcroft-Gault formula. Scand J Clin Lab Invest 2005;65:153-162.
16. Grubb A, Nyman U, Bjork J, et al: Simple cystatin C-based prediction equations for glomerular filtration rate compared with the modification of diet in renal disease prediction equation for adults and the Schwartz and the Counahan-Barratt prediction equations for children. Clin Chem 2005;51:1420-1431.
17. Finney H, Newman DJ, Gruber W, et al: Initial evaluation of cystatin C measurement by particle-enhanced immunonephelometry on the Behring nephelometer systems (BNA, BN II). Clin Chem 1997;43:1016-1022.
18. Mussap M, Ruzzante N, Varagnolo M, Plebani M: Quantitative automated particle-enhanced immunonephelometric assay for the routinary measurement of human cystatin C. Clin Chem Lab Med 1998;36:859-865.
19. Herget-Rosenthal S, Feldkamp T, Volbracht L, Kribben A: Measurement of urinary cystatin C by particle-enhanced nephelometric immunoassay: precision, interferences, stability and reference range. Ann Clin Biochem 2004;41:111-118.
20. Zahran A, Qureshi M, Shoker A: Comparison between creatinine and cystatin C-based GFR equations in renal transplantation. Nephrol Dial Transplant 2007;22:2659-2668.
21. Ruiz R, Borque L, Soria AG, et al: Evaluation of an immunoturbidimetric assay of serum digoxin without sample pretreatment. Eur J Clin Chem Clin Biochem 1995;33:171-175.
22. Borque L, Maside C, Iglesias A: Automated turbidimetry of serum lipoprotein(a). Eur J Clin Chem Clin Biochem 1993;31:869-874.
23. Borque L, Maside C, Rus A, del Cura J: Automated determination of apolipoproteins A-I and B with an improved immunoturbidi-metric assay using Boehringer-Mannheim and Hitachi analyzer systems. Clin Biochem 1993;26:471-476.
24. Tian S, Kusano E, Ohara T, et al: Cystatin C measurement and its practical use in patients with various renal diseases. Clin Nephrol 1997; 48:104-108.
25. Xu X, Zou J, Ding X, et al: Clinical value of serum cystatin C by ELISA for estimation of glomerular filtration rate. J Clin Lab Anal 2004;18:61-64.
26. Marx GM, Blake GM, Galani E, et al: Evaluation of the Cockroft-Gault, Jelliffe and Wright formulae in estimating renal function in elderly cancer patients. Ann Oncol 2004; 15:291-295.
27. Coutsias E A, Seok C, Dill KA: Using quaternions to calculate RMSD. J Comput Chem 2004;25:1849-1857.
28. Maiorov VN, Crippen GM: Significance of root-mean-square deviation in comparing three-dimensional structures of globular proteins. J Mol Biol 1994;235:625-634.
29. Whelton PK, Gordis L: Epidemiology of clinical medicine. Epidemiol Rev 2000;22:140-144.
30. Bland JM, Altman DG: Statistical methods for assessing agreement between two methods of clinical measurement. Lancet 1986; 1:307-310.
31. Langlotz CP: Fundamental measures of diagnostic examination performance: usefulness for clinical decision-making and research. Radiology 2003;228:3-9.
32. Coll E, Botey A, Alvarez L, et al: Serum cystatin C as a new marker for noninvasive estimation of glomerular filtration rate and as a marker for early renal impairment. Am J Kidney Dis 2000;36:29-34.
33. Royakkers A A, van Suijlen JD, Hofstra LS, et al: Serum cystatin C-A useful endogenous marker of renal function in intensive care unit patients at risk for or with acute renal failure? Curr Med Chem 2007; 14:2314-2317.
34. Lewis AV, James TJ, McGuire JB, Taylor RP: Improved immunoturbidimetric assay for cystatin C. Ann Clin Biochem 2001;38:111-114.
35. Borrows R, Cockwell P: Measuring renal function in solid organ transplant recipients. Transplantation 2007;83:529-531.